CoChat

Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged Prednisolone Therapy in Infants

Mendoza-Cruz, A. Czarina, Wargon, Orli, Adams, Susan, Tran, Huy, Verge, Charles F. · 2013 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

CONTEXT: The duration of hypothalamic-pituitary-adrenal (HPA) axis suppression after glucocorticoid treatment is uncertain. OBJECTIVE: We aimed to determine the duration of HPA axis suppression in prednisolone-treated infants and the age at which circadian variation in salivary cortisol is established in healthy infants. DESIGN, SETTING, AND PARTICIPANTS: Before the adoption of propranolol treatment by the Vascular Birthmarks Clinic, 12 infants with infantile hemangioma received high-dose prednisolone for 12 to 25 weeks' duration, weaned over 4 to 6 weeks, and ceased at age 21 to 31 weeks. Parents collected serial salivary samples at two time points per day (before first and last feed) until circadian variation in salivary cortisol (measured by radioimmunoassay) was observed, when a confirmatory 1 μg Synacthen test was performed. Ten healthy control infants had serial salivary cortisol measurements to determine the age at which circadian variation is established. MAIN OUTCOME MEASURE: We defined circadian variation as evening salivary cortisol <50% of the early morning level on two consecutive sampling weeks. RESULTS: Circadian variation appeared within 6 weeks (median 2.7, range 1.4-5.4) of prednisolone cessation. All confirmatory Synacthen tests were normal (peak serum cortisol >600 nmol/L) and were performed within 12 weeks of prednisolone cessation. Healthy controls developed circadian variation at median 16 weeks of age (range 8-24). CONCLUSION: HPA recovery occurred within 6 to 12 weeks, shorter than empirical recommendations, to give stress cover for 6 to 12 months. Reduced duration of stress-cover precautions may reduce parental anxiety and side effects from unnecessary glucocorticoid use. Healthy control infants established circadian variation in salivary cortisol between 2 and 6 months of age.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2013-2649

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 20 · Cited by 16

Metadata

Authors
Mendoza-Cruz, A. C., Wargon, O., Adams, S., Tran, H., & Verge, C. F.
Affiliations
  • UNSW Sydney (AU)
  • University of Newcastle Australia (AU)
Corresponding author
Verge, Charles F.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-12
Volume
98
Issue
12
Pages
E1936-E1940
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2023005414
Cited by
16
References
20
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
hypothalamic-pituitary-adrenal axis, prednisolone, glucocorticoid suppression, infantile hemangioma, salivary cortisol, circadian rhythm, ACTH stimulation test, infants
MeSH terms
Child Development, Circadian Rhythm, Female, Follow-Up Studies, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Infant, Male, Neoplastic Syndromes, Hereditary, Pituitary-Adrenal System, Prednisolone, Prospective Studies, Saliva, Time Factors, Hemangioma, Capillary, Antineoplastic Agents, Hormonal, Recovery of Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged Prednisolone Therapy in Infants. https://app.cochat.ai/papers/10.1210/jc.2013-2649
The paper
Mendoza-Cruz, A. C., Wargon, O., Adams, S., Tran, H., & Verge, C. F. (2013). Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged Prednisolone Therapy in Infants. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-2649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.